Key Insights

Highlights

Success Rate

97% trial completion (above average)

Published Results

13 trials with published results (5%)

Research Maturity

105 completed trials (44% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

1.3%

3 terminated out of 237 trials

Success Rate

97.2%

+10.7% vs benchmark

Late-Stage Pipeline

13%

31 trials in Phase 3/4

Results Transparency

12%

13 of 105 completed with results

Key Signals

13 with results97% success

Data Visualizations

Phase Distribution

141Total
Not Applicable (71)
Early P 1 (1)
P 1 (21)
P 2 (17)
P 3 (11)
P 4 (20)

Trial Status

Completed105
Recruiting56
Unknown38
Not Yet Recruiting15
Active Not Recruiting10
Enrolling By Invitation7

Trial Success Rate

97.2%

Benchmark: 86.5%

Based on 105 completed trials

Clinical Trials (237)

Showing 20 of 20 trials
NCT05797246Phase 2Active Not Recruiting

Bevacizumab in Adults With Recurrent Respiratory Papillomatosis (RRP)

NCT00006150RecruitingPrimary

Natural History, Management, and Genetics of the Hyperimmunoglobulin E Recurrent Infection Syndrome (HIES)

NCT02505386Phase 4CompletedPrimary

Pharmacokinetics of Ertapenem in Patients Aged Over 75

NCT07220915Phase 3Recruiting

Supporting Weak Immune System During Autoimmune Therapy: Testing Panzyga to Prevent Infections

NCT05978037Phase 1Completed

A Study to Assess the Safety and Effectiveness of Two Experimental Malaria Vaccines

NCT07607470Recruiting

Large Algorithm Setting and Validation Study

NCT00967785Phase 1Recruiting

A Phase I Study of Mozobil in the Treatment of Patients With WHIMS

NCT02231879Phase 2Completed

Plerixafor Versus G-CSF in the Treatment of People With WHIM Syndrome

NCT06002685Not ApplicableActive Not Recruiting

Partners in Children's Health (CSN): A Randomized Trial of an Attachment Based Intervention

NCT05947955Phase 2Recruiting

Rhu-pGSN for Acute Respiratory Distress Syndrome (ARDS)

NCT05180110Completed

A Performance Evaluation of the LumiraDx Point of Care CRP Assay

NCT05699174Phase 3RecruitingPrimary

PO vs IV Antibiotics for the Treatment of Infected Nonunion of Fractures After Fixation

NCT07598006Completed

Hypervirulent Amoxicillin-Susceptible Klebsiella Pneumoniae CC66, France, 2016-2023

NCT05422326Phase 2Completed

A Study to Evaluate Safety and Immunogenicity of One or Two Booster Vaccinations With H5N6 Influenza Vaccine in Adults Primed With H5N1 Influenza Vaccine or Unprimed

NCT06702878Phase 3Completed

Light-Activated Antimicrobial Therapy to Prevent Surgical Site Infections

NCT07189858Not ApplicableCompleted

Light-Activated Antimicrobial Therapy to Prevent Surgical Site Infections - Canada

NCT07034573Completed

Evaluation of a Ventilation-filtration System for Operating Rooms at the Protestant Hospital of Mbouo (VENTI-MBOUO)

NCT05471973Not ApplicableRecruitingPrimary

CIED Infection Quality Initiative Demonstration Project

NCT05846438Not ApplicableRecruitingPrimary

Effect of Drain Care on Infection Rate and Quality of Life in Implant-Based Breast Reconstruction.

NCT06092866Not ApplicableCompletedPrimary

Digital Versus Telephone Symptom Assessment and Triage in Primary Care

Scroll to load more

Research Network

Activity Timeline